These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8096127)

  • 1. Halothane and the guanylate cyclase system.
    Nakamura K; Toda H; Hatano Y
    Anesthesiology; 1993 Mar; 78(3):617-8. PubMed ID: 8096127
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of guanylate cyclase-cGMP systems in halothane-induced vasodilation in canine cerebral arteries.
    Eskinder H; Hillard CJ; Flynn N; Bosnjak ZJ; Kampine JP
    Anesthesiology; 1992 Sep; 77(3):482-7. PubMed ID: 1355637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
    Yu SM; Kuo SC
    Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
    Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
    J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
    Waldman SA; Murad F
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
    Mülsch A; Busse R; Bassenge E
    Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
    Mülsch A; Busse R; Bassenge E
    Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
    Onoue H; Katusic ZS
    Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
    Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide and cytosolic guanylate cyclase: components of an intercellular signalling system.
    Böhme E; Schmidt HH
    Z Kardiol; 1989; 78 Suppl 6():75-9. PubMed ID: 2575829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxynitrite stimulates vascular smooth muscle cell cyclic GMP synthesis.
    Tarpey MM; Beckman JS; Ischiropoulos H; Gore JZ; Brock TA
    FEBS Lett; 1995 May; 364(3):314-8. PubMed ID: 7758588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle.
    Beasley D
    Am J Physiol; 1990 Jul; 259(1 Pt 2):R38-44. PubMed ID: 1695820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyanide on nitrovasodilator-induced relaxation, cyclic GMP accumulation and guanylate cyclase activation in rat aorta.
    Rapoport RM; Murad F
    Eur J Pharmacol; 1984 Sep; 104(1-2):61-70. PubMed ID: 6149944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of atrial natriuretic peptide on cyclic GMP system in vascular smooth muscle.
    Mittal CK
    Indian J Exp Biol; 1987 Jan; 25(1):24-8. PubMed ID: 2886423
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS; Cantor E; Ho E; Walega M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
    Jing M; Ling GS; Bina S; Hart JL; Muldoon SM
    Eur J Pharmacol; 1998 Jan; 342(2-3):217-24. PubMed ID: 9548389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
    Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
    Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atriopeptin II and nitrovasodilator-mediated shifts in guanosine 3',5'-cyclic monophosphate in rat thoracic aorta: evidence for involvement of distinct guanylate cyclase pools.
    Mittal CK
    Eur J Pharmacol; 1985 Sep; 115(1):127-8. PubMed ID: 2864274
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic GMP in vasodilation.
    Murad F; Leitman DC; Bennett BM; Molina C; Waldman SA
    Am J Med Sci; 1987 Sep; 294(3):139-43. PubMed ID: 2889359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.